224 related articles for article (PubMed ID: 31118799)
21. Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852.
Ouyang H; Zhang L; Xie Z; Ma S
Exp Ther Med; 2019 Oct; 18(4):2547-2553. PubMed ID: 31572506
[TBL] [Abstract][Full Text] [Related]
22. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
23. Low expression of long non-coding RNA ARAP1-AS1 can inhibit lung cancer proliferation by inducing G0/G1 cell cycle organization.
Tao X; Zhang Y; Li J; Ni Z; Tao Z; You Q; He Z; Huang D; Zheng S
J Thorac Dis; 2020 Dec; 12(12):7326-7336. PubMed ID: 33447422
[TBL] [Abstract][Full Text] [Related]
24. Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma.
Sun J; Chen W; Wen B; Zhang M; Sun H; Yang X; Zhao W; La L; An H; Pang J; Gao L; He S
Front Pharmacol; 2021; 12():610158. PubMed ID: 33762939
[TBL] [Abstract][Full Text] [Related]
25. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
26. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer.
Shi XY; Sun YZ; Li M; Li HY
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):232-238. PubMed ID: 31389606
[TBL] [Abstract][Full Text] [Related]
27. lncRNA PCBP1-AS1 Aggravates the Progression of Hepatocellular Carcinoma via Regulating PCBP1/PRL-3/AKT Pathway.
Luo T; Gao Y; Zhangyuan G; Xu X; Xue C; Jin L; Zhang W; Zhu C; Sun B; Qin X
Cancer Manag Res; 2020; 12():5395-5408. PubMed ID: 32753957
[TBL] [Abstract][Full Text] [Related]
28. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
29. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
30. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA OIP5-AS1 accelerates the ox-LDL mediated vascular endothelial cells apoptosis through targeting GSK-3β via recruiting EZH2.
Wang M; Liu Y; Li C; Zhang Y; Zhou X; Lu C
Am J Transl Res; 2019; 11(3):1827-1834. PubMed ID: 30972206
[TBL] [Abstract][Full Text] [Related]
32. LncZEB1-AS1 regulates hepatocellular carcinoma bone metastasis via regulation of the miR-302b-EGFR-PI3K-AKT axis.
Ma ZJ; Wang Y; Li HF; Liu MH; Bi FR; Ma L; Ma H; Yan HL
J Cancer; 2020; 11(17):5118-5128. PubMed ID: 32742459
[TBL] [Abstract][Full Text] [Related]
33. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma.
Chen J; Wu D; Zhang Y; Yang Y; Duan Y; An Y
Clin Sci (Lond); 2019 Jan; 133(2):367-379. PubMed ID: 30617187
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation expression of TGFB2-AS1 inhibits the proliferation, migration, invasion and induces apoptosis in HepG2 cells.
Liu W; Huai R; Zhang Y; Rao S; Xiong L; Ding R; Mao C; Zhao W; Hao T; Huang Q; Guo Z
Genes Genomics; 2019 Aug; 41(8):951-959. PubMed ID: 31066006
[TBL] [Abstract][Full Text] [Related]
35. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
[TBL] [Abstract][Full Text] [Related]
36. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
[TBL] [Abstract][Full Text] [Related]
37. MiR-194 promotes hepatocellular carcinoma through negative regulation of CADM1.
Niu X; Nong S; Gong J; Zhang X; Tang H; Zhou T; Li W
Int J Clin Exp Pathol; 2020; 13(7):1518-1528. PubMed ID: 32782670
[TBL] [Abstract][Full Text] [Related]
38. A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular carcinoma progression through stabilizing HHIP mRNA.
Bo C; Li X; He L; Zhang S; Li N; An Y
Biochem Biophys Res Commun; 2019 Dec; 520(2):333-340. PubMed ID: 31604528
[TBL] [Abstract][Full Text] [Related]
39. The lncRNA B3GALT5-AS1 Functions as an HCC Suppressor by Regulating the miR-934/UFM1 Axis.
Chen E; Zhou B; Bian S; Ni W; Chen Z
J Oncol; 2021; 2021():1776432. PubMed ID: 34721576
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
Ji D; Wang Y; Sun B; Yang J; Luo X
Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
